• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Maquet Culture













































I just don't get it. Why all the bashing of this company? They seem to be good and well managed....are they not? Does anyone know anything other than the innuendo and games on the board? Or just all a bunch of jilted ex-employees who couldn't hack it?